11.10.2021Aura Biosciences Presents Interim Phase 2 Safety Data Evaluating Suprachoroidal Administration of AU-011 in Patients with Choroidal Melanoma at the ASRS 2021 Annual Meeting

Press Release
29.09.2021Aura Biosciences Expands Executive Leadership Team and Board of Directors

Press Release
21.09.2021Dr. Carolin Barth Joins MiroBio as CEO to Lead Precision Immunology Company Focused on Checkpoint Agonist Antibodies

Press Release
21.09.2021Amphista Therapeutics Appoints New Chairman, Joshua T. Brumm

Press Release
15.09.2021Rappta Therapeutics Appoints Sunjeet Sawhney as Chief Executive Officer

Press Release
09.09.2021Eloxx Pharmaceuticals Announces Fast Track Designation for ELX-02 for the Treatment of Cystic Fibrosis Patients with Nonsense Mutations

Press Release
02.09.2021Orphalan announces FDA acceptance for filing of New Drug Application (NDA) for trientine tetrahydrochloride (TETA 4HCl) for the treatment of Wilson’s Disease

Press Release
13.07.2021Artax Biopharma Granted MHRA Clinical Trial Authorization for AX-158

Press Release
07.07.2021NeRRe Therapeutics raises £20 million in a Series B2 financing round

Press Release
28.06.2021Amphista Therapeutics Expands Research Team by Appointing Martin O’Rourke as Head of Drug Discovery and James Osborne as Director of Chemistry

Press Release